Professor Richard Weller, Professor of Medical Dermatology at the University of Edinburgh and Honorary Consultant Dermatologist, added, Atopic dermatitis, a lifelong condition without a cure, greatly benefits from the expanding range of biologic treatments like lebrikizumab, now reimbursed by NICE, thereby enhancing treatment options for patients. NICEs endorsement of lebrikizumab represents a pivotal development in the treatment landscape for moderate to severe Atopic Dermatitis, offering hope for improved quality of life for many affected individuals.
At the same time, more data are needed to clarify which patient populations benefit most
Prostate 80 , 367375 (2020)
If your metabolism runs fast, youll probably notice the benefits wear off sooner
Krishnan A, Venkataraman J (2011) Prevalence of nonalcoholic fatty liver disease and its biochemical predictors in patients with type-2 diabetic mellitus